APA (7th ed.) Citation

Liang, Z., Liu, L., Li, W., Lai, H., Li, L., Wu, J., . . . Fang, C. (2023, October). Efficacy and safety of zolbetuximab for first-line treatment of advanced Claudin 18. 2-positive gastric or gastro-esophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Liang, Zhanpeng, Liwen Liu, Wenxia Li, Huiqin Lai, Luzhen Li, Jiaming Wu, Huatang Zhang, and Cantu Fang. "Efficacy and Safety of Zolbetuximab for First-line Treatment of Advanced Claudin 18. 2-positive Gastric or Gastro-esophageal Junction Adenocarcinoma: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Frontiers in Oncology Oct. 2023.

MLA (9th ed.) Citation

Liang, Zhanpeng, et al. "Efficacy and Safety of Zolbetuximab for First-line Treatment of Advanced Claudin 18. 2-positive Gastric or Gastro-esophageal Junction Adenocarcinoma: A Systematic Review and Meta-analysis of Randomized Controlled Trials." Frontiers in Oncology, Oct. 2023.